Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
581 studies found for:    HAART
Show Display Options
Rank Status Study
21 Completed Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting;   HIV Infections
Interventions: Drug: Dronabinol;   Drug: Placebo
22 Active, not recruiting New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
Condition: HIV Infections
Intervention: Drug: 2 NRTI + 1 PI/r + Maraviroc + Raltegravir
23 Unknown  Effects of a Phone Call Intervention to Promote HAART Adherence
Condition: Medication Adherence
Intervention: Behavioral: Phone call intervention, no phone call intervention
24 Completed
Has Results
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
Condition: HIV Infection
Interventions: Biological: DermaVir;   Drug: HAART
25 Completed Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.
Conditions: HIV-associated Hypertriglyceridemia;   HIV-associated Hypercholesterolemia;   HIV-associated Inflammatory State
Intervention: Drug: Docosahexaenoic acid (DHA) administration to modulate Triglycerides in HIV patients under HAART
26 Completed LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Conditions: HIV Infections;   Diffuse Large B Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: Highly active antiretroviral therapy;   Drug: Central nervous system (CNS) prophylaxis;   Drug: Prophylaxis of opportunistic infections and support treatment
27 Withdrawn Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine
28 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
29 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
30 Unknown  A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
31 Unknown  Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
Condition: HIV
Intervention: Drug: Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
32 Completed The HAART 300 Annuloplasty Ring Extended Safety and Performance Trial Used in Surgical Repair of the Aortic Valve
Condition: Aortic Insufficiency
Intervention: Device: HAART 300 Annuloplasty Ring
33 Completed Long Term Treatment Interruptions
Conditions: HIV Infections;   AIDS
Interventions: Other: STI;   Drug: stable HAART
34 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
35 Active, not recruiting Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
36 Unknown  Social-Psychological Intervention to Improve Adherence to HAART
Conditions: AIDS;   HIV Infections
Interventions: Behavioral: Social-psycho intervention to improve adherence to HAART;   Other: Usual care
37 Unknown  Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Intervention: Other: Comparison of different treatment strategies
38 Active, not recruiting Intense Acute Infection Study
Condition: Acute HIV Infection
Interventions: Drug: raltegravir;   Drug: maraviroc;   Drug: emtricitabine 200mg /tenofovir 300mg;   Drug: lopinavir 400 mg/ritonavir 100mg
39 Completed Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
40 Completed
Has Results
Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Pre-study antiretroviral regimen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years